Xu J L, Guo Y. Clinical characteristics and survival of extrapulmonary small cell carcinoma in 11 different primary tumor sites in the united states, 1975-2016[J]. Curr Med Res Opin, 2021, 37(1): 71-81.
[3]
Oneda E, Zorzi F, Gorio A, et al. Differential diagnosis of small cell carcinoma of the ovary or ovarian metastases of small cell carcinoma of the lung: a case report and review of the literature[J]. Case Rep Oncol, 2020, 13(2): 822-828.
[4]
Wharton D, Kim E, Pagan J, et al. Patterns of care and outcomes for small cell carcinoma of the cervix: a national retrospective analysis of 542 cases[J]. Adv Radiat Oncol, 2020, 5(3): 412-418.
[5]
Kitajima K, Kihara T, Kawanaka Y, et al. Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis-Japan multicenter study[J]. Oncotarget, 2020, 11(40): 3675-3686.
[6]
Elsherif S, Odisio E, Faria S, et al. Imaging and staging of neuroendocrine cervical cancer[J]. Abdom Radiol (NY), 2018, 43(12): 3468-3478.
[7]
Tempfer C B, Tischoff I, Dogan A, et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature[J]. BMC Cancer, 2018, 18(1): 530.
Kuji S, Hirashima Y, Nakayama H, et al. Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; kansai clinical oncology group/intergroup study in Japan[J]. Gynecol Oncol, 2013, 129(3): 522-527.
Chen M Y, Chou H H, Liu FY, et al. 18F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up[J]. Eur J Nucl Med Mol Imaging, 2016, 43(4): 663-674.
2021, Vol. 32 
